Statistics for Medpace Holdings (id:7307 MEDP)

Valuation metrics

Market cap

9.60B

Enterprise value

9.13B

Trailing P/E (ttm)

27.03

Forward P/E

24.73

PEG ratio

24.73

Price/Sales (ttm)

4.64

Price/Book (mrq)

10.87

Enterprise Value/Revenue

4.41

Enterprise Value/EBITDA

20.86

Overview

Shares outstanding

31.08M

Float

25.47M

Shares short

1.10M

% Held by insiders

0.18%

% Held by institutions

0.86%

Average volume (10 days)

435.91K

Average volume (90 days)

Price summary

52-Week low

268.80

52-Week high

459.77

52-Week change

15.05%

Beta

1.37

50-Day moving average

341.51

200-Day moving average

378.78

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

17.66%

Operating margin

21.05%

Operational effectiveness

Return on assets

14.31%

Return on equity

54.08%

Income statement

Revenue (ttm)

67.02

Revenue per share (ttm)

67.02

Quarterly revenue growth (yoy)

0.37

Gross profit (ttm)

524.50M

EBITDA

439.73M

Net income to common (ttm)

365.57M

Diluted EPS (ttm)

11.43

Quarterly earnings growth (yoy)

36.70%

Balance sheet

Total cash (mrq)

656.90M

Total cash per share (mrq)

21.18

Total debt (mrq)

151.89M

Total Debt/Equity (mrq)

17.23

Current ratio (mrq)

99.20%

Book value per share (mrq)

28.42

Cash flow

Cash flow statement

574.54M

Levered free cash flow (LFCF)

437.60M